機械学習による同類酵素の阻害特異性の修正
Dor S Gozlan1, Reut Meiri2, Gili Shapira1
1Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
The FEBS journal
|September 5, 2025
まとめ
機械学習は選択的なプロテアゼ阻害剤の設計を簡素化します 新しいN-TIMP2変種は,マトリックス金属タンパク質酵素 (MMPs) に対する選択性が向上し,実験の努力が減り,同類酵素の標的化が改善された.
科学分野:
- 生物化学と分子生物学
- コンピュータ生物学
- 薬物の発見
背景:
- 選択的酵素阻害剤は,標的治療と生物学的研究において極めて重要です.
- 特定の阻害剤,特に同類酵素の設計は,実験的なスケールと特異性チューニングで課題に直面しています.
- タンパク質設計の現在の機械学習 (ML) のアプローチは,エネルギー計算の精度と多変異効果の予測によって制限されています.
研究 の 目的:
- 選択性プロテアゼ阻害剤の設計のための新しいMLベースの方法を開発し,検証する.
- 同種酵素の特異性プロファイルに合わせた阻害剤の特定を簡素化する.
- マトリックス金属タンパク質酶 (MMP) の選択的阻害剤を設計するためにこの方法を適用する.
主な方法:
- MLモデルによる高通量スクリーニング (HTS) データを活用して,予測型結合親和性を訓練する.
- MMP-1,MMP-3,MMP-9を標的とした新しいN-TIMP2の設計
- 設計された変異体の結合親和性と選択性の実験的検証.
- 構造的な洞察のために 分子モデリングとエネルギー最小化を使用します
主要な成果:
- MMP-1,MMP-3,MMP-9の異なる特異性プロファイルを持つ新しいN-TIMP2の設計に成功しました.
- 実験的検証により,野生型N-TIMP2と比較して,有意な特異性シフトと強化された選択性が確認されました.
- 構造分析は,変異体の改善された選択性の分子基盤に関する洞察を提供した.
結論:
- 開発されたMLベースの方法は,抑制剤の設計における実験作業量を効果的に軽減します.
- このアプローチは,同類酵素ファミリーの高度選択的阻害剤の合理的な設計を容易にする.
- この研究は,酵素-阻害剤の相互作用と選択的標的の理解を進める.
関連する概念動画
Enzyme Inhibition
79.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.5K
Enzymes
82.5K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
82.5K
Induced-fit Model
82.1K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
82.1K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
Allosteric Regulation
59.0K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
59.0K


